This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5mu8
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 5mu8 is ON HOLD Authors: Description: Category: Unreleased Structures) |
|||
| (3 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525== | |
| + | <StructureSection load='5mu8' size='340' side='right'caption='[[5mu8]], [[Resolution|resolution]] 3.00Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[5mu8]] is a 48 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5MU8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5MU8 FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=JNI:~{N}4-(PHENYLMETHYL)-~{N}4-[2-[3-(2-PIPERAZIN-1-YLPYRIMIDIN-5-YL)PHENYL]PHENYL]PYRIMIDINE-2,4-DIAMINE'>JNI</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5mu8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5mu8 OCA], [https://pdbe.org/5mu8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5mu8 RCSB], [https://www.ebi.ac.uk/pdbsum/5mu8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5mu8 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Disease == | ||
| + | [https://www.uniprot.org/uniprot/TNFA_HUMAN TNFA_HUMAN] Genetic variations in TNF are a cause of susceptibility psoriatic arthritis (PSORAS) [MIM:[https://omim.org/entry/607507 607507]. PSORAS is an inflammatory, seronegative arthritis associated with psoriasis. It is a heterogeneous disorder ranging from a mild, non-destructive disease to a severe, progressive, erosive arthropathy. Five types of psoriatic arthritis have been defined: asymmetrical oligoarthritis characterized by primary involvement of the small joints of the fingers or toes; asymmetrical arthritis which involves the joints of the extremities; symmetrical polyarthritis characterized by a rheumatoidlike pattern that can involve hands, wrists, ankles, and feet; arthritis mutilans, which is a rare but deforming and destructive condition; arthritis of the sacroiliac joints and spine (psoriatic spondylitis). | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/TNFA_HUMAN TNFA_HUMAN] Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation.<ref>PMID:16829952</ref> The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells.<ref>PMID:16829952</ref> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | A prevalent observation in high-throughput screening and drug discovery programs is the inhibition of protein function by small-molecule compound aggregation. Here, we present the X-ray structural description of aggregation-based inhibition of a protein-protein interaction involving tumor necrosis factor alpha (TNFalpha). An ordered conglomerate of an aggregating small-molecule inhibitor (JNJ525) induces a quaternary structure switch of TNFalpha that inhibits the protein-protein interaction between TNFalpha and TNFalpha receptors. SPD-304 may employ a similar mechanism of inhibition. | ||
| - | + | Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein-Protein Interaction.,Blevitt JM, Hack MD, Herman KL, Jackson PF, Krawczuk PJ, Lebsack AD, Liu AX, Mirzadegan T, Nelen MI, Patrick AN, Steinbacher S, Milla ME, Lumb KJ J Med Chem. 2017 Mar 16. PMID:28300404<ref>PMID:28300404</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[Category: | + | </div> |
| + | <div class="pdbe-citations 5mu8" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Tumor necrosis factor|Tumor necrosis factor]] | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Blevitt JM]] | ||
| + | [[Category: Hack MD]] | ||
| + | [[Category: Herman KL]] | ||
| + | [[Category: Jackson PF]] | ||
| + | [[Category: Krawczuk PJ]] | ||
| + | [[Category: Lebsack AD]] | ||
| + | [[Category: Liu AX]] | ||
| + | [[Category: Lumb KJ]] | ||
| + | [[Category: Milla ME]] | ||
| + | [[Category: Mirzadegan T]] | ||
| + | [[Category: Nelen MI]] | ||
| + | [[Category: Patrick AP]] | ||
| + | [[Category: Steinbacher S]] | ||
Current revision
HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
| |||||||||||
Categories: Homo sapiens | Large Structures | Blevitt JM | Hack MD | Herman KL | Jackson PF | Krawczuk PJ | Lebsack AD | Liu AX | Lumb KJ | Milla ME | Mirzadegan T | Nelen MI | Patrick AP | Steinbacher S
